Home
ENA Emergency Nursing 2015 Conference
Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I Disorder
Description:
● Provide an overview of the prevalence and burden of agitation associated with schizophrenia or bipolar I disorder
● Identify unmet needs in the acute management of agitation associated with schizophrenia or bipolar I disorder
● Discuss currently available therapies for patients presenting with agitation associated with schizophrenia or bipolar I disorder
● Describe the pharmacology, efficacy, and safety of an acute treatment option for agitation associated with schizophrenia or bipolar I disorder in adults
Date:
10/02/2015
Time:
11:30 AM – 1:00 PM
Location:
Orange County Convention Center
W304A-D
Orlando, Florida 32819
Speakers:
Paul Berkowitz, MD, FAPM
Director of Behavioral Health
Centegra Health System
Behavioral Health Medical Director
Centegra Health & Wellness Network
Woodstock, Illinois
Sponsored by
If you are licensed in any state or other jurisdiction or are an employee or contractor of any organization or governmental
entity that limits or prohibits meals from pharmaceutical companies, please identify yourself so that you (and we) are able
to comply with such requirements. Your name, the value, and purpose of any educational item, meal, or other items of value
you received may be reported as required by state or federal law. Once reported, this information may be publicly accessible. Thank you for your cooperation.
This is a promotional event. CME/CE credit will not be available for this session.
In compliance with PhRMA guidelines, spouses or other guests are not permitted to attend company-sponsored programs. This
promotional educational activity is brought to you by Teva Select Brands and is not certified for continuing medical education.
The speakers are presenting on behalf of Teva Select Brands and must present information in compliance with FDA requirements
applicable to Teva Select Brands.